Table 2.
Psychoactive drugs and other treatments in Sub-threshold Depression (HRDS > 10 without lifetime criteria for Depressive Episode) by sex
| Treatment | Males | % | Females D | % | Total (males and females) | % | OR (F) | CL 95% | Χ2 1df | P |
|---|---|---|---|---|---|---|---|---|---|---|
| First-line Antidepressants° | 2 | 6.8 | 18 | 16.6 | 20 | 14.6 | 2.7 | 0.1-96.4 | 1.05 | 0.30 |
| Second-line Antidepressants§ | 1 | 3.4 | 6 | 5.6 | 7 | 5.1 | 1.6 | 0.1-31.2 | 0.1 | 0.98 |
| Benzodiazepines* | 7 | 24.1 | 33 | 30.6 | 40 | 24.1 | 1.4 | 0.2-6.3 | 0.2 | 0.66 |
| Homeopathics | 1 | 3.4 | 3 | 2.7 | 4 | 2.9 | 0.8 | 0.3-2.1 | 0.2 | 0.68 |
| Psychotherapy | 3 | 10.3 | 10 | 9.2 | 13 | 9.5 | 0.9 | 0.4-2.0 | 0.1 | 0.86 |
°SSRI, TCA, IMAO, SNRI, NaSSA, bupriopion; § low-dosage benzamides, low-dosage quetiapine, trazodone, nefazodone, Adenosin-methionine, Hypericum Perforatum